← Back to headlines

Massive Wegovy Sales Could Lead to Novo Nordisk Upgrade
Strong sales of the weight-loss drug Wegovy are anticipated to potentially trigger an upward revision of financial forecasts for pharmaceutical giant Novo Nordisk.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.



